Aislinn Santoni

‘A solid evidence base is vital for creating impactful policy changes in health and ensuring health equity for all. I am excited at the prospect that my work can contribute to these advancements and help improve health systems and people’s experiences of them.’

Aislinn joined The Health Policy Partnership in July 2023 and is currently working on projects in chronic respiratory diseases and heart valve disease.

Before joining HPP, Aislinn worked in the primary care policy and research policy sectors. While at the Royal College of General Practitioners, she worked on developing the College’s clinical policy programme, focusing on women’s health, cholesterol management and multiple long-term conditions. Her work at the Institute of Cancer Research involved improving access to cancer medications and influencing for more innovative drug development by engaging with patients and national bodies to showcase the need for, and potential of, greater availability of cutting-edge medicines.

Aislinn holds a Master of Research degree in Cardiovascular Science from the University of Birmingham, with her dissertation investigating the role of FGF23 in cardiac fibrosis. She gained an undergraduate degree in Medical Science from the University of Birmingham.